Famotidine
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sagent Pharmaceuticals | generic | 6 | SUPPLYING |
| Fresenius Kabi, USA LLC | generic | 4 | SUPPLYING |
| HF Acquisition Co. LLC, DBA HealthFirst | repackager | 2 | SUPPLYING |
| Baxter Healthcare Corporation | brand | 1 | SUPPLYING |
| Medical Purchasing Solutions, LLC | repackager | 1 | SUPPLYING |
| Athenex Pharmaceutical Division, LLC. | unknown | 1 | EXITED 2026 |
Shortages, recalls, and registration changes attached to this drug concept.
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing. — Recalling firm: Fresenius Kabi USA, LLC — Nationwide within the United States as well as AK, HI, and PR.
TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state. — Recalling firm: HF Acquisition Co. LLC — The vials were distributed to one consignee located in CT.
Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers. — Recalling firm: Baxter Healthcare Corp. — Nationwide
